Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2021 06:30 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based...
September 01, 2021 06:30 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

WALTHAM, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...
August 10, 2021 16:22 ET | Source: Adagio Therapeutics, Inc.

Adagio Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based...